Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/26/24 EDT
883.20UNCH (UNCH)
Volume
30,344
Close
883.20quote price arrow down-7.48 (-0.84%)
Volume
474,984
52 week range
684.80 - 998.33
Loading...
  • Open881.72
  • Day High887.48
  • Day Low875.22
  • Prev Close890.68
  • 52 Week High998.33
  • 52 Week High Date02/28/24
  • 52 Week Low684.80
  • 52 Week Low Date06/28/23

Key Stats

  • Market Cap96.942B
  • Shares Out109.76M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta0.17
  • YTD % Change0.56

KEY STATS

  • Open881.72
  • Day High887.48
  • Day Low875.22
  • Prev Close890.68
  • 52 Week High998.33
  • 52 Week High Date02/28/24
  • 52 Week Low684.80
  • 52 Week Low Date06/28/23
  • Market Cap96.942B
  • Shares Out109.76M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta0.17
  • YTD % Change0.56

RATIOS/PROFITABILITY

  • EPS (TTM)34.76
  • P/E (TTM)25.41
  • Fwd P/E (NTM)19.46
  • EBITDA (TTM)4.654B
  • ROE (TTM)16.26%
  • Revenue (TTM)13.117B
  • Gross Margin (TTM)86.16%
  • Net Margin (TTM)30.14%
  • Debt To Equity (MRQ)10.41%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Regeneron Pharmaceuticals Inc

Profile

MORE
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic conditions, infectious diseases, and rare diseases. It helps in accelerating and improving the...
Christopher Fenimore
Chief Financial Officer, Senior Vice President - Finance
Daniel Van Plew
Executive Vice President, General Manager - Industrial Operations and Product Supply
Marion McCourt
Executive Vice President - Commercial
Andrew Murphy Ph.D.
Executive Vice President - Research
Neil Stahl Ph.D.
Executive Vice President - Research and Development
Jason Pitofsky
Vice President, Controller
Address
777 Old Saw Mill River Road
Tarrytown, NY
10591
United States

Top Peers

SYMBOLLASTCHG%CHG
BIIB
Biogen Inc
208.90+6.44+3.18%
MRNA
Moderna Inc
107.97+1.79+1.69%
NVZMY
Novozymes A/S
55.76+0.41+0.74%
ILMN
Illumina Inc
122.28+1.23+1.02%
BNTX
Biontech SE
87.21+0.50+0.58%